Ausgabe 4/2009
Inhalt (10 Artikel)
- Clinical Trials Report
Chemoimmunotherapy with modified dosing of fludarabine, cyclophosphamide, and rituximab shows significant clinical activity in patients with previously untreated chronic lymphocytic leukemia
Nicole Lamanna, Mark A. Weiss
The host-tumor interface in B-cell non-Hodgkin lymphoma: A new world to investigate
Nicolas Rachinel, Gilles Salles
Prognostic factors in low-grade non-Hodgkin lymphomas
Massimo Federico, Stefano Molica, Monica Bellei, Stefano Luminari
Beyond R-CHOP and the IPI in large-cell lymphoma: Molecular markers as an opportunity for stratification
Jason R. Westin, Luis E. Fayad
Update on the World Health Organization classification of peripheral T-cell lymphomas
Hilary M. O’Leary, Kerry J. Savage
Hemopoietic stem cell transplantation in T-cell malignancies: Who, when, and how?
Francesco d’Amore, Esa Jantunen, Thomas Relander